Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome
- 1 September 2015
- journal article
- case report
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 116 (1-2) , 35-43
Abstract
No abstract availableKeywords
Funding Information
- Pyridoxine Dependent Epilepsy Foundation
- BC Children's Hospital Foundation, Vancouver, Canada
This publication has 45 references indexed in Scilit:
- Pyridoxine-dependent Epilepsy With Elevated Urinary α-Amino Adipic Semialdehyde in Molybdenum Cofactor DeficiencyPediatrics, 2012
- Hippocampal sclerosis—Origins and imagingEpilepsia, 2012
- Differential topochemistry of three cationic amino acid transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brainAmino Acids, 2012
- Profound Neonatal Hypoglycemia and Lactic Acidosis Caused by Pyridoxine-Dependent EpilepsyPediatrics, 2012
- The measurement of urinary Δ1‐piperideine‐6‐carboxylate, the alter ego of α‐aminoadipic semialdehyde, in Antiquitin deficiencyJournal of Inherited Metabolic Disease, 2012
- Diagnosis and management of glutaric aciduria type I – revised recommendationsJournal of Inherited Metabolic Disease, 2011
- Pyridoxal 5'‐phosphate in cerebrospinal fluid; factors affecting concentrationJournal of Inherited Metabolic Disease, 2011
- Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registryEuropean Journal of Pediatrics, 2008
- B6‐responsive disorders: A model of vitamin dependencyJournal of Inherited Metabolic Disease, 2005
- Mesial Temporal Lobe Epilepsy with Hippocampal SclerosisEpilepsia, 2004